{
    "2020-10-29": [
        [
            {
                "time": "2020-10-29",
                "original_text": "Regeneron Posts Positive Data For Covid-19 Treatment; Lung Cancer Drug Advances",
                "features": {
                    "keywords": [
                        "Regeneron",
                        "Positive",
                        "Covid-19",
                        "Treatment",
                        "Lung Cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "ETFs to Shine on Lilly's U.S. Deal for Coronavirus Antibody",
                "features": {
                    "keywords": [
                        "ETFs",
                        "Lilly",
                        "U.S.",
                        "Deal",
                        "Coronavirus",
                        "Antibody"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "IBD 50 Stocks To Watch: Pharma That Treated Trump Is Building Base",
                "features": {
                    "keywords": [
                        "IBD 50",
                        "Stocks",
                        "Pharma",
                        "Trump",
                        "Building Base"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "Is Eli Lilly and Company (NYSE:LLY) Trading At A 35% Discount?",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Discount",
                        "Trading"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "Incyte (INCY) to Post Q3 Earnings: Will Jakafi Drive Results?",
                "features": {
                    "keywords": [
                        "Incyte",
                        "Q3 Earnings",
                        "Jakafi"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "Amgen (AMGN) Losing Altitude Despite Strong Quarter",
                "features": {
                    "keywords": [
                        "Amgen",
                        "Losing Altitude",
                        "Strong Quarter"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "Column: While decrying 'socialized medicine,' Trump spends billions on COVID drugs",
                "features": {
                    "keywords": [
                        "Trump",
                        "Socialized Medicine",
                        "COVID Drugs"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "government"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "New Data at EADV 2020 Confirm TaltzÂ® (ixekizumab) Demonstrates Sustained Long-Term Efficacy in Patients with Psoriasis and Psoriatic Arthritis",
                "features": {
                    "keywords": [
                        "Taltz",
                        "EADV 2020",
                        "Psoriasis",
                        "Psoriatic Arthritis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "Eli Lilly Strikes $375M Covid-19 Antibody Supply Deal With US Government",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Covid-19",
                        "Antibody",
                        "Supply Deal",
                        "US Government"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-10-29",
                "original_text": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eli Lilly and Company - LLY",
                "features": {
                    "keywords": [
                        "Pomerantz Law Firm",
                        "Investigates",
                        "Claims",
                        "Eli Lilly",
                        "Investors"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "legal",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}